Abstract: An exoskeleton robotic equipment for tenodesis grasp and release training includes an exoskeleton mechanism and a control device. The exoskeleton mechanism includes a fixing seat worn on a forearm, an actuating device mounted to the fixing seat, and a transmission module connected to the fixing seat and pivotally connected to the actuating device and cooperating with the fixing seat and the actuating device to form a four-bar linkage mechanism. The actuating device is controlled by the control device to drive the transmission module to move relative to the fixing seat to change the transmission module into a release state and into a grasp state so as to move the index finger and the middle finger away from and toward the thumb.

Abstract: Artificial synaptic devices with an HfO2-based ferroelectric layer that can be implemented in the CMOS back-end are provided. In one aspect, an artificial synapse element is provided. The artificial synapse element includes: a bottom electrode; a ferroelectric layer disposed on the bottom electrode, wherein the ferroelectric layer includes an HfO2-based material that crystallizes in a ferroelectric phase at a temperature of less than or equal to about 400° C.; and a top electrode disposed on the bottom electrode. An artificial synaptic device including the present artificial synapse element and methods for formation thereof are also provided.

Abstract: The present invention features compositions and methods featuring ALT-803, a complex of an interleukin-15 (IL-15) superagonist mutant and a dimeric IL-15 receptor ?/Fc fusion protein useful for enhancing an immune response against a neoplasia (e.g., multiple myeloma, melanoma, lymphoma) or a viral infection (e.g., human immunodeficiency virus).

Abstract: Described herein is a crossbar array that includes a cross-point synaptic device at each of a plurality of crosspoints. The cross-point synaptic device includes a weight storage element comprising a set of nanocrystal dots. Further, the cross-point synaptic device includes at least three terminals for interacting with the weight storage element, wherein a weight is stored in the weight storage element by sending a first electric pulse via a gate terminal from the at least three terminals, the first electric pulse causes the nanocrystal dots to store a corresponding charge, and the weight is erased from the weight storage element by sending a second electric pulse via the gate terminal, the second electric pulse having an opposite polarity of the first electric pulse.

Abstract: A mechanical energy harvesting system includes a base seat unit, a rotating shaft device, and a driving device. The base seat unit includes first and second seat bodies. The rotating shaft device is rotatably mounted to the first seat body. The driving device is disposed on the base seat unit and includes at least one driving unit sleeved on the rotating shaft device for driving the rotating shaft device to rotate and thus generate rotational kinetic energy, and at least one transmission unit connected between the second seat body and the driving unit and configured to drive the rotating shaft device to rotate when the second seat body swings relative to the first seat body, so as to generate the rotational kinetic energy.

Abstract: A camera device is provided. The camera device includes: a first imaging section, a second imaging section, a third imaging section, and a processor. The first imaging section, second imaging section, and third imaging section capture a first image, a second image, and a third image of a scene with a first field of view (FOV), a second FOV, and a third FOV. The processor is configured to generate a first output image by performing a first image-fusion process on at least two of the first image, the second image, and the third image in response to a zooming factor of the camera device being between a first zooming factor and a second zooming factor, wherein the first FOV is wider than the second FOV, and the second FOV is wider than the third FOV, and the second zooming factor is greater than the first zooming factor.

Abstract: The present invention features compositions and methods featuring ALT-803, a complex of an interleukin-15 (IL-15) superagonist mutant and a dimeric IL-15 receptor ?/Fc fusion protein useful for enhancing an immune response against a neoplasia (e.g., multiple myeloma, melanoma, lymphoma) or a viral infection (e.g., human immunodeficiency virus).

Abstract: A method is presented for incorporating a metal-ferroelectric-metal (MFM) structure in a cross-bar array in back end of the line (BEOL) processing. The method includes forming a first electrode, forming a ferroelectric layer in direct contact with the first electrode, forming a second electrode in direct contact with the ferroelectric layer, such that the first electrode and the ferroelectric layer are perpendicular to the second electrode to form the cross-bar array, and biasing the second electrode to adjust domain wall movement within the ferroelectric layer.

Abstract: A method of fabricating a symmetric element of a resistive processing unit (RPU) includes forming a substrate with a channel region connecting two doped regions, and forming a source above one of the two doped regions and a drain above the other of the two doped regions. A gate is formed above the channel region, and a bar ferroelectric is disposed above the channel region and below the gate.

Abstract: Embodiments may also include a residual chemical reaction diagnostic device. The residual chemical reaction diagnostic device may include a substrate and a residual chemical reaction sensor formed on the substrate. In an embodiment, the residual chemical reaction sensor provides electrical outputs in response to the presence of residual chemical reactions. In an embodiment, the substrate is a device substrate, and the sensor is formed in a scribe line of the device substrate. In an alternative embodiment, the substrate is a process development substrate. In some embodiments, the residual chemical reaction sensor includes, a first probe pad, wherein a plurality of first arms extend out from the first probe pad, and a second probe pad, wherein a plurality of second arms extend out from the second probe pad and are interdigitated with the first arms.

Abstract: Implementations of the present disclosure generally relate to methods and apparatuses for epitaxial deposition on substrate surfaces. More particularly, implementations of the present disclosure generally relate to methods and apparatuses for surface preparation prior to epitaxial deposition. In one implementation, a method of processing a substrate is provided. The method comprises etching a surface of a silicon-containing substrate by use of a plasma etch process, where at least one etching process gas comprising chlorine gas and an inert gas is used during the plasma etch process and forming an epitaxial layer on the surface of the silicon-containing substrate.

Abstract: Disclosed herein are programmable, conditionally activated small interfering RNA constructs (Cond-siRNAs) and methods of making and using the same as therapeutic agents. The Cond-siRNA comprises a sensor strand, a core strand, and a guide strand, which crossover to form a sensor duplex and a RNAi duplex attached to each other to form a single structure. Upon binding an input strand to the sensor strand, the Cond-siRNA is activated and releases RNAi targeting a desired gene.

Abstract: Contemplated compositions and methods comprise chimeric molecule complexes that advantageously provide activating signaling to immune competent cells when bound to ALL cells. Furthermore, chimeric molecule complexes include an Fc portion to extend serum half live time and facilitate purification.

Abstract: The present invention features compositions and methods featuring ALT-803, a complex of an interleukin-15 (IL-15) superagonist mutant and a dimeric IL-15 receptor ?/Fc fusion protein useful for enhancing an immune response against a neoplasia (e.g., multiple myeloma, melanoma, lymphoma) or a viral infection (e.g., human immunodeficiency virus).

Abstract: An mechanical energy harvesting system includes a base seat unit, a rotating shaft device, and a driving device. The base seat unit includes first and second seat bodies. The rotating shaft device is rotatably mounted to the first seat body. The driving device is disposed on the base seat unit and includes at least one driving unit sleeved on the rotating shaft device for driving the rotating shaft device to rotate and thus generate rotational kinetic energy, and at least one transmission unit connected between the second seat body and the driving unit and configured to drive the rotating shaft device to rotate when the second seat body swings relative to the first seat body, so as to generate the rotational kinetic energy.

Abstract: An interactive control method is provided. The interactive control method includes the following steps. When robot equipment is located outside elevator equipment, the robot equipment is connected to a first control module disposed outside the elevator equipment to call, by the first control module, an elevator car of the elevator equipment. The first control module determines whether the elevator car arrives at a current floor to return an arrival signal to the robot equipment. The robot equipment is connected to a second control module disposed inside the elevator car according to the arrival signal to control, by the second control module, an elevator door of the elevator car to open. The robot equipment is driven to move into the elevator car. When the robot equipment is located within a working range of the elevator car, the second control module stops controlling the elevator door of the elevator car to open.

Abstract: Disclosed herein are conditional siRNAs activatable by CBF?-MYH11 oncogenic gene and use thereof for treating conditions such as acute myeloid leukemia (AML). The conditional siRNAs target MCL-1 or HDAC8.

Abstract: A device includes a sensor configured to provide a temperature-sensitive voltage and an oscillator. The sensor includes: a first transistor, being a diode-connected transistor; a second transistor coupled between a source of the first transistor and ground, wherein a gate of the second transistor is controllable by an enable signal; and a current source configured to control the first transistor and comprising a third transistor, a drain of which is directly connected to a drain of the first transistor, the third transistor being a diode-connected transistor. The oscillator includes: a digital delay cell; and an adjustment device configured to, based on the temperature-sensitive voltage, adjust a delay of the digital delay cell. The digital delay cell produces, based on the adjusted delay, a signal at an oscillation frequency.

Abstract: The present invention features compositions and methods featuring ALT-803, a complex of an interleukin-15 (IL-15) superagonist mutant and a dimeric IL-15 receptor ?/Fc fusion protein useful for enhancing an immune response against a neoplasia (e.g., multiple myeloma, melanoma, lymphoma) or a viral infection (e.g., human immunodeficiency virus).

Abstract: A device includes a sensor and an oscillator. The sensor provides a temperature-sensitive voltage. The oscillator includes a digital delay cell and an adjustment device. The adjustment device, based on the temperature-sensitive voltage, adjusts a delay of the digital delay cell, wherein the digital delay cell produces, based on the adjusted delay, a signal at an oscillation frequency.